| Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem? KS Steinsbekk, B Kåre Myskja, B Solberg European Journal of Human Genetics 21 (9), 897-902, 2013 | 328 | 2013 |
| The moral difference between intragenic and transgenic modification of plants BK Myskja Journal of Agricultural and Environmental Ethics 19, 225-238, 2006 | 100 | 2006 |
| The Sublime in Kant and Beckett: aesthetic judgement, ethics and literature BK Myskja Walter de Gruyter, 2002 | 63 | 2002 |
| The categorical imperative and the ethics of trust BK Myskja Ethics and Information Technology 10, 213-220, 2008 | 50 | 2008 |
| Non-safety assessments of genome-edited organisms: should they be included in regulation? BK Myskja, AI Myhr Science and Engineering Ethics 26 (5), 2601-2627, 2020 | 45 | 2020 |
| A novel governance framework for GMO: A tiered, more flexible regulation for GMO s would help to stimulate innovation and public debate S Bratlie, K Halvorsen, BK Myskja, H Mellegård, C Bjorvatn, P Frost, ... EMBO reports 20 (5), e47812, 2019 | 45 | 2019 |
| We have never been ELSI researchers–there is no need for a post-ELSI shift BK Myskja, R Nydal, AI Myhr Life Sciences, Society and Policy 10, 1-17, 2014 | 43 | 2014 |
| Lay expertise: why involve the public in biobank governance? BK Myskja Genomics, Society and Policy 3 (1), 1, 2007 | 30 | 2007 |
| Precaution or integrated responsibility approach to nanovaccines in fish farming? A critical appraisal of the UNESCO precautionary principle AI Myhr, BK Myskja Nanoethics 5, 73-86, 2011 | 29 | 2011 |
| Personalized medicine, digital technology and trust: a Kantian account BK Myskja, KS Steinsbekk Medicine, Health Care and Philosophy 23, 577-587, 2020 | 22 | 2020 |
| Conscientious objection to intentional killing: an argument for toleration BK Myskja, M Magelssen BMC medical ethics 19, 1-9, 2018 | 21 | 2018 |
| Think global, buy national: CSR, cooperatives and consumer concerns in the Norwegian food value chain L Ursin, BK Myskja, SG Carson Journal of Agricultural and Environmental Ethics 29, 387-405, 2016 | 19 | 2016 |
| From ethics of restriction to ethics of construction: ELSA research in Norway R Nydal, AI Myhr, BK Myskja Nordic Journal of Science and Technology Studies 3 (1), 34-45, 2015 | 18 | 2015 |
| Rationality and religion in the public debate on embryo stem cell research and prenatal diagnostics BK Myskja Medicine, Health Care and Philosophy 12, 213-224, 2009 | 16 | 2009 |
| The ethics of access to patented biotech research tools from universities and other research institutions KJ Egelie, SP Strand, B Johansen, BK Myskja Nature Biotechnology 36 (6), 495-499, 2018 | 9 | 2018 |
| Trust, lies and virtuality B Myskja | 9 | 2011 |
| From idealism to realism: Commercial ventures in publicly funded biobanks KS Steinsbekk, B Solberg, BK Myskja New challenges for biobanks: Ethics, law and governance (GeneBanC project …, 2009 | 9 | 2009 |
| Appreciation Through Use: How Industrial Technology Articulates an Ecology of Values Around Norwegian Seaweed S Efstathiou, BK Myskja Philosophy & Technology 32, 405-424, 2019 | 7 | 2019 |
| Vurderingskriteriet etikk: Veileder for operasjonalisering av vurderingskriteriet etikk i genteknologiloven EM Forsberg, B Hofmann, M Kaiser, BK Myskja, R Strand, L Ursin Cristin-resultat-ID, 2019 | 6 | 2019 |
| Assistert befruktning og familieverdier i forandring: Er vi på et moralsk skråplan? BK Myskja nytt norsk tidsskrift 33 (1-2), 45-59, 2016 | 6 | 2016 |
